Skip to main content
Fig. 2 | Cardiovascular Ultrasound

Fig. 2

From: Echocardiographic characteristics of PRKAG2 syndrome: a research using three-dimensional speckle tracking echocardiography compared with sarcomeric hypertrophic cardiomyopathy

Fig. 2

There were significant differences in HR, LVESD, SV, and GLS between PRKAG2 syndrome and sarcomeric HCM patients. HR and LVESD of PRKAG2 LVH also had significant differences compared with healthy volunteers. * refers to P < 0.05 between the PRKAG2 syndrome group and the healthy group. ** refers to P < 0.05 between the PRKAG2 syndrome group and the sarcomeric HCM group

Back to article page